Learn

Basel, Switzerland is the ideal location for this symposium, as it has a rich history in the life sciences and is home to many of the world's leading pharmaceutical companies who are at the forefront of drug discovery research.

Additionally, the city has earned the reputation of being "Europe's Booming Biotech Powerhouse" due to its thriving network of biotech startups.

By attending this symposium, you will have the opportunity to learn from leading experts in the Basel life sciences industry about the latest developments in data pipelines for drug discovery research, how clinics are using data science to improve patient outcomes and the latest advancements in AI and machine learning.

This year's session topics include:

Data Pipelines in Drug Discovery Research
Session Co-Chairs: Steven van Helden, Ph.D. (Pivot Park Screening Centre) and Mohit Goel, M.S. (Moderna)
This session explores how data flows from instruments capturing raw data to data mining applications where data is translated into meaningful results.

Data Science in Clinics
Session Chair: Abdullah Kahraman, Ph.D. (FHNW University of Applied Sciences and Arts Northwestern Switzerland)
This session showcases how data science drives precision medicine in hospitals.

Biomarker Detection Using Omics
Session Chair: Kalyani Gampa, M.S. (Novartis)
This session will provide information on how next-gen sequencing platforms like proteomics and RNA-Seq help establish gene signatures and PD markers in a disease-relevant context. 

The Influence of Machine Learning and Artificial Intelligence
Session Chair: Joshua Kangas, Ph.D. (Carnegie Mellon University)
This session will explore current applications of machine learning and AI for experimental design and direction as well as the application of predictive modeling for a variety of applications.

Keynote Speakers